Allied Market Research

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market growth.

WILMINGTON, Del., Feb. 16, 2026 /PRNewswire/ -- Allied Market Research published a report, titled, "Genotyping Market by Product (Instruments, Reagents and Kits and Software and Services), Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the genotyping market was valued at $16.8 billion in 2023, and is estimated to reach $61.6 billion by 2033, growing at a CAGR of 13.8% from 2024 to 2033.

Prime determinants of growth  

The surge in prevalence of genetic disorders worldwide, such as cancer, cardiovascular diseases, and neurological disorders, shift towards personalized medicine, and increase in demand for forensic DNA analysis are the major factors that drive the growth of the genotyping market. However, the high cost of genotyping technologies restricts market growth. Moreover, advancements in genomic research offers remunerative opportunities for the expansion of the global genotyping market.  

Request Sample of the Report on Global Genotyping Market 2033 - https://www.alliedmarketresearch.com/request-sample/840

Report coverage & details

Report Coverage	Details
Forecast Period	2024–2033
Base Year	2023
Market Size in 2023	$16.8 billion
Market Size in 2033	$61.6 billion
CAGR	13.8 %